article thumbnail

Chemical synthesis: containment challenges for HPAPI handling

Pharmaceutical Technology

These facilities are often multi-use CMO facilities, which combined with the use of HPAPIs, require stringent containment solutions to prevent cross-contamination. Solutions for Handling Nanogram Level Potent Products to Pass Containment Testing Criteria Webinar. Chemical synthesis solutions. Free Webinar. By ILC Dover. United Kingdom.

article thumbnail

Bromodomain Containing Protein 4 drugs in development, 2023

Pharmaceutical Technology

GlobalData’s report assesses the drugs in the Bromodomain Containing Protein 4 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

GELATIN-Free Medicines: Which Drugs Contain GELATIN?

Drug Patent Watch

Buy Gelatin-Free Medicines on Amazon This guide is designed to provide information for healthcare providers to… The post GELATIN-Free Medicines: Which Drugs Contain GELATIN? GELATIN-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs.

article thumbnail

LACTOSE-Free Medicines: Which Drugs Contain LACTOSE?

Drug Patent Watch

Buy Lactose-Free Medicines from Amazon This guide is designed to provide information for healthcare providers to… The post LACTOSE-Free Medicines: Which Drugs Contain LACTOSE? LACTOSE-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs.

article thumbnail

UK MHRA publishes guidance on medicines containing valproate

Pharmaceutical Technology

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published updated guidance on valproate-containing medicines.

article thumbnail

Why choosing the right primary container is crucial

Bio Pharma Dive

New mRNA technology: identifying the right drug containment solution is more important than ever.

article thumbnail

How API CMOs can improve containment capabilities without facility acquisition

Pharmaceutical Technology

According to GlobalData analysis, specialist small molecule API capabilities such as containment or controlled substances are driving large contract manufacturing organisations (CMOs) to acquire facilities. Flexible containment solutions for potent APIs. Partnering with containment experts.